Published Mar 26, 2019

Abcuro announces pre-clinical data on new immuno-oncology target

Member News

Related or similar articles

May 6, 2025

How AI is Revolutionizing Biotech—and Why Labshares Remains the Ideal Home for Emerging Biotechs

AI is transforming biotech by accelerating drug discovery, diagnostics, and research. Emerging AI-biotech companies still need flexible wet lab space, advanced equipment, and experimental validation to bring discoveries to market.
Blog Posts
December 10, 2021

Labshares Newton Doubles Space for Emerging Biotech Startups

Labshares Newton celebrated today the opening of 19,000 square feet of new incubator lab space and expects to open another 6,000-foot lab in September. Labshares’ new space incorporates 12 private lab suites and 15 benches.
Labshares News
October 9, 2024

Explore Labshares' Latest High-Tech Equipment Advancements

Labshares expands its advanced equipment offerings for cell sorting, protein analysis, and flow cytometry.
Labshares News